Enzolytics (ENZC) Rebounding From The Lows: Should You Buy?

The Enzolytics Inc (OTC: ENZC) stock has been in focus among investors in recent weeks and it seems it was back in focus on Wednesday.

Back on Tuesday, the company made a significant announcement with regards to its interests in a company in Bulgaria. The announcement seems to have come as a positive trigger for the Enzolytics stock and yesterday, it surged by as high as 14%. The company announced on Tuesday that it submitted the Articles of Association with regards to the formation of the Bulgarian LLP (limited liability company) International Medical Partners.

Enzolytics is a 50% owner in the company. International Medical Partners is going to be involved with the certification and initial production of patented therapies meant for treating HIV. Eventually, the company plans to have clinical trials for these therapies under the rules laid down by the European Medicine Agency. These are important developments and investors could consider keeping an eye out for further developments.

Alex Krakowsky

Editor in Chief.Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life